23 October 2026RSS feed
PR●Press Release IndiaTHE BUSINESS ANNOUNCEMENT WIRE
Business announcements.
Direct from the source.
NEWSROOM / INDIA

November 2021

Browse announcements from the Press Release India archive.

UPDATED THROUGHOUT THE DAY
Business wire72

Takeda’s LIVTENCITYTM (maribavir) Approved by U.S. FDA as the First and Only Treatment for People Ages 12 and Older with Post-Transplant Cytomegalovirus (CMV), Refractory (With or Without Genotypic Resistance) to Conventional Antiviral Therapies

- In the Phase 3 SOLSTICE study, more than twice the proportion of adult transplant recipients with refractory or resistant (R/R) CMV infection/disease achieved confirmed CMV DNA level <LLOQ at Week 8 with LIVTENCITY (56%; n=131/235), compared to those treated

Business wire74

ORIGYN Foundation Receives Strategic Investment of $20M from World-Renowned Investors, including Bill Ackman's Table Management, Polychain Capital, Paris Hilton, Coinko and Vectr Ventures

● ORIGYN Foundation valued at $300 million by exclusive set of investors in a select, private round to bring NFTs to life ● Strategic raise will launch ORIGYN Foundation’s verticals to market in the art, collectibles, digital media and luxury sectors, as well